A patent is a government-issued legal monopoly that grants an inventor exclusive rights to make, use, and sell their invention for a limited time—usually 20 years from the filing date. Patents apply to new products, processes, machines, or compositions of matter that are novel, non-obvious, and useful. When you invest in a startup with strong patent protection, you're investing in a defensible business with barriers to competition.
How It Works
The patent process begins with filing an application with the appropriate government office, such as the U.S. Patent and Trademark Office (USPTO). The application includes a detailed description of the invention, drawings, and claims that define what is protected. After examination—which typically takes 2-4 years—the patent is either granted or rejected. Once granted, the patent owner can enforce their rights by suing infringers or licensing the technology to others for royalties.
There are three main types of patents: utility patents (for how something works or what it does), design patents (for appearance), and plant patents (for new plant varieties). Utility patents are most relevant to investors, as they protect the core technology of a business.
Why It Matters for Investors
Patents are critical assets in due diligence. A strong patent portfolio can justify premium valuations, create sustainable competitive advantages, and provide revenue streams through licensing. Companies with patents are harder to replicate and give investors longer runways to achieve profitability before facing direct competition.
However, not all patents are equally valuable. A patent covering a core technology in a large market is far more valuable than one covering a niche feature. Smart investors evaluate patent quality, breadth of claims, and enforceability—not just the number of patents filed. They also consider whether patents are pending or granted, as granted patents offer more certainty.
Example
Imagine you're evaluating two biotech startups. Company A has developed a novel cancer treatment and holds three granted patents covering the drug mechanism, delivery system, and manufacturing process. Company B has similar science but no patents yet. Both have the same technology, but Company A's patents create a 20-year window of exclusive market access, potentially justifying a 5-10x higher valuation. This IP protection is what transforms an interesting technology into an investable asset.
Key Takeaways
- Patents provide exclusive legal rights to an invention for approximately 20 years, creating a competitive moat
- Granted patents are more valuable than pending applications; evaluate patent quality and breadth, not just quantity
- Strong patent portfolios significantly impact startup valuations and can generate revenue through licensing deals
- Always assess whether a company's patents cover core technology or peripheral features when evaluating investment quality